Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Victory Square Technologies Ranks No. 2 Among Publicly Traded Companies on The Globe and Mail's 2026 Canada's Top Growing Companies List

      Victory Square Technologies Logo

      News provided by

      Victory Square Technologies Inc

      Oct 06, 2026, 08:00 ET

      Share this article

      Share this article


      VST places No. 58 overall with 497% three-year revenue growth; portfolio spans U.S. healthcare infrastructure, peptide drug delivery and pet health

      VANCOUVER, BC, Oct. 6, 2026 /PRNewswire/ -- Victory Square Technologies Inc. ("Victory Square", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a publicly traded venture builder, is pleased to announce that it has ranked No. 58 overall on The Globe and Mail's 2026 Report on Business ranking of Canada's Top Growing Companies, achieving 497% revenue growth from 2022 to 2025.

      Victory Square also holds the second-highest position among the 24 publicly traded companies included in the ranking, based on the Company's review of the published list filtered by publicly traded status.

      The 497% increase represents nearly a sixfold expansion in revenue over the measurement period. The recognition comes as Victory Square continues to scale its consolidated operations while developing businesses across healthcare infrastructure, biotechnology and pet health.

      "Behind this recognition are years of building, teams that kept executing and shareholders who supported us along the way," said Shafin Diamond Tejani, CEO of Victory Square Technologies. "Placing second among the publicly traded companies on this list is a proud moment for everyone involved. It reflects meaningful progress in turning the businesses we help build into operations with real commercial scale."

      Continued growth beyond the ranking period

      The ranking measures revenue growth through 2025. Victory Square's previously announced results show continued expansion in the first half of 2026:

      • Consolidated revenue of $53.0 million, compared with $9.9 million in the first half of 2025, an increase of approximately 434%.
      • Consolidated gross profit of $10.5 million, compared with $3.4 million in the corresponding period.
      • Consolidated cash of $20.2 million and working capital of $34.5 million as at June 30, 2026.

      First-half consolidated revenue growth was primarily attributable to Hydreight Technologies Inc., Victory Square's largest operating subsidiary.

      All financial amounts are in Canadian dollars. Readers should review the Company's financial statements and Management's Discussion and Analysis on SEDAR+ for additional information.

      What investors gain exposure to through VST

      Victory Square provides public-market investors with exposure to operating and development-stage technology businesses through a single publicly traded company. Its approach combines investment capital with operational support, strategic guidance and industry relationships to help businesses develop and scale.

      Current areas of focus include:

      Hydreight Technologies — U.S. healthcare infrastructure

      Hydreight (TSXV: NURS) operates a digital health infrastructure platform supporting healthcare providers, businesses and direct-to-consumer healthcare brands across all 50 U.S. states. Its platform brings together technology, physician coverage, pharmacy relationships and compliance infrastructure. Hydreight is the principal driver of Victory Square's consolidated revenue.

      Insu Therapeutics — Peptide drug delivery

      Insu is developing technology designed to deliver peptide-based medicines through the inner cheek, known as buccal delivery. Its research includes evaluating the delivery of existing therapies such as semaglutide through an alternative route of administration. Insu remains a development-stage biotechnology business; clinical validation and applicable regulatory approvals are required before commercialization.

      Pawsible Ventures — Building pet-health businesses

      Pawsible is a pet-health venture platform supporting founders across veterinary technology and animal wellness. In April 2026, it announced its inaugural cohort of eight companies, selected from several hundred applicants globally. The cohort spans veterinary infrastructure, diagnostics, AI-enabled care, preventative health and consumer wellness, giving Pawsible a concrete starting point for applying Victory Square's venture-building approach to companion-animal health.

      These businesses represent different stages of development. Hydreight provides established commercial operations, while Insu and Pawsible offer exposure to earlier-stage opportunities with distinct development and execution risks.

      "Our model gives investors a way to participate in businesses they might otherwise encounter only through private markets," added Tejani. "We work alongside founders and management teams to help those businesses move forward. Our priorities are to support execution, allocate capital carefully and translate portfolio progress into long-term value for VST shareholders."

      Meet the portfolio: October 8 investor webinar

      Victory Square invites existing shareholders and prospective investors to its Corporate and Portfolio Update on Thursday, October 8, 2026, at 2:00 p.m. Pacific Time.

      The webinar will include a closer look at Hydreight, Insu Therapeutics and Pawsible Ventures, alongside other public and private holdings. Management will discuss net asset value, capital allocation and how progress across the portfolio can translate into value for VST shareholders.

      The event will include a live shareholder Q&A.

      Register for the webinar

      On behalf of the Board of Directors

      Shafin Diamond Tejani
      Chairman & Chief Executive Officer
      Victory Square Technologies Inc.

      About Canada's Top Growing Companies

      Canada's Top Growing Companies is an editorial ranking published by The Globe and Mail's Report on Business magazine. Launched in 2019, the voluntary program ranks qualifying Canadian businesses based on three-year revenue growth following an application and review process.

      The 2026 ranking is available in the October issue of Report on Business magazine and online at The Globe and Mail.

      About Victory Square Technologies Inc.

      Victory Square builds, acquires and invests in technology companies, providing capital, strategic leadership and operational support to help them develop and scale. Its portfolio includes operating and development-stage businesses across healthcare infrastructure, digital health, artificial intelligence, pet health and other emerging technology sectors.

      Headquartered in Vancouver, Canada, Victory Square trades on the Canadian Securities Exchange, the OTCQX market and the Frankfurt Stock Exchange.

      For more information, visit www.victorysquare.com.

      Forward-Looking Information

      This news release contains forward-looking information within the meaning of applicable securities laws, including statements concerning Victory Square's business strategy, portfolio development, capital allocation, potential shareholder value, Insu Therapeutics' drug-delivery technology and potential commercialization, Pawsible Ventures' development opportunities, and the timing and content of the planned investor webinar.

      Such information is based on management's current expectations and assumptions, including the availability of capital, demand for portfolio companies' products and services, successful research and development, receipt of applicable regulatory approvals and the ability to execute business plans. Actual results may differ materially due to risks including market and economic conditions, financing requirements, competition, regulatory changes, clinical and technological uncertainty, and operational execution. Additional risks are described in the Company's public filings on SEDAR+.

      Historical revenue growth and inclusion in an editorial ranking do not guarantee future operating results or investment returns. Readers should not place undue reliance on forward-looking information. The Company undertakes no obligation to update such information except as required by applicable law.

      SOURCE Victory Square Technologies Inc

      Modal title

      Also from this source

      Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform

      Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform

      Victory Square Technologies Inc. ("Victory Square," "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6) today announced that portfolio...

      Victory Square Technologies Reports First-Half 2026 Revenue of $53.0 Million and Net Income of $6.5 Million

      Victory Square Technologies Reports First-Half 2026 Revenue of $53.0 Million and Net Income of $6.5 Million

      Victory Square Technologies Inc. ("Victory Square", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6), a venture builder focused on...

      More Releases From This Source

      Explore

      Magazines

      Magazines

      Biotechnology

      Biotechnology

      Pharmaceuticals

      Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.